Ramachandran Meenakshisundaram
Ramachandran Meenakshisundaram has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Subramanian Senthilkumaran
Department of Emergency & Critical Care, Manian Medical Centre, Erode, India
5 shared publicationsPonniah Thirumalaikolundusubramanian
Trichy SRM Medical College Hospital and Research Centre, Irungalur, Tiruchirapalli 621105, India
4 shared publicationsNarendra Nath Jena
Meenakshi Mission Hospital and Research Centre, Madurai, Tamil Nadu, India
2 shared publications- Ponniah Thirumalaikolundusubramanian
Department of General Medicine, The Tamil Nadu Dr M.G.R Medical University, Chennai 600032, Tamil Nadu, India
2 shared publications Shyamsundar Ayyasamy
Apollo Specialty Hospitals, Tiruchirappalli, Tamil Nadu, India
2 shared publications- V. P. Chandrasekaran
Sri Gokulam Specialty Hospitals, Salem, Tamil Nadu, India
2 shared publications
Latest Publications
- Open Access
- 2 June 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 7 (6) , ytad192
Ivabradine for inappropriate sinus tachycardia-induced symptomatic Mobitz type I atrio-ventricular block: a case summary
Background: Inappropriate sinus tachycardia (IST) is characterized by a continuum of symptoms, and the aetiology of IST is imprecise. IST-induced autonomic dysfunction is well known, but IST-induced atrio-ventricular block is not reported to our knowledge. Case summary: A 67-year-old female presented with a 4-day history of random intermittent difficulty in breathing, chest tightness, palpitations, and dizziness, with a recorded heart rate of 30 beats per minute (BPM) on home monitoring equipment. The initial electrocardiogram (ECG) demonstrated sinus rhythm with intermittent Mobitz type I second degree atrio-ventricular (AV) block, with continuous cardiac monitoring demonstrating frequent episodes of Wenckebach phenomenon throughout the day, with a sinus rate of 100–120 BPM. Echocardiogram showed no significant structural abnormalities. The patient was on bisoprolol, and hence, it was suspected Wenckebach may be due to that and so stopped. However, there was no tangible effect on rhythm 48 hours after stopping bisoprolol, leading to a suspicion of IST-induced Mobitz type I second degree AV block; and so decided to introduce ivabradine 2.5 mg twice daily. After 24 hours of Ivabradine, the patient remained in sinus rhythm with no documented episodes of Wenckebach phenomenon on cardiac monitor, a finding subsequently confirmed by 24-hour Holter monitoring. During a recent follow-up visit in clinic, the patient remained symptom-free, with an ECG demonstrating sinus rhythm at a physiological rate. Discussion: Mobitz type I second degree AV block is usually due to reversible conduction block at the level of the AV node whereby malfunctioning AV nodal cells tend to progressively fatigue until they fail to conduct an impulse. Under conditions of increased vagal tone and autonomic dysfunction, Wenckebach occurrence will be increased. Thus, selective impulse conduction within the sinoatrial (SA) node by ivabradine to reduce beat conduction to the AV node in patients with IST/dysautonomia-induced Mobitz type I AV will reduce the occurrence of Wenckebach.
- 2 June 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 7 (6) , ytad192
Open AccessIvabradine for inappropriate sinus tachycardia-induced symptomatic Mobitz type I atrio-ventricular block: a case summary
Background: Inappropriate sinus tachycardia (IST) is characterized by a continuum of symptoms, and the aetiology of IST is imprecise. IST-induced autonomic dysfunction is well known, but IST-induced atrio-ventricular block is not reported to our knowledge. Case summary: A 67-year-old female presented with a 4-day history of random intermittent difficulty in breathing, chest tightness, palpitations, and dizziness, with a recorded heart rate of 30 beats per minute (BPM) on home monitoring equipment. The initial electrocardiogram (ECG) demonstrated sinus rhythm with intermittent Mobitz type I second degree atrio-ventricular (AV) block, with continuous cardiac monitoring demonstrating frequent episodes of Wenckebach phenomenon throughout the day, with a sinus rate of 100–120 BPM. Echocardiogram showed no significant structural abnormalities. The patient was on bisoprolol, and hence, it was suspected Wenckebach may be due to that and so stopped. However, there was no tangible effect on rhythm 48 hours after stopping bisoprolol, leading to a suspicion of IST-induced Mobitz type I second degree AV block; and so decided to introduce ivabradine 2.5 mg twice daily. After 24 hours of Ivabradine, the patient remained in sinus rhythm with no documented episodes of Wenckebach phenomenon on cardiac monitor, a finding subsequently confirmed by 24-hour Holter monitoring. During a recent follow-up visit in clinic, the patient remained symptom-free, with an ECG demonstrating sinus rhythm at a physiological rate. Discussion: Mobitz type I second degree AV block is usually due to reversible conduction block at the level of the AV node whereby malfunctioning AV nodal cells tend to progressively fatigue until they fail to conduct an impulse. Under conditions of increased vagal tone and autonomic dysfunction, Wenckebach occurrence will be increased. Thus, selective impulse conduction within the sinoatrial (SA) node by ivabradine to reduce beat conduction to the AV node in patients with IST/dysautonomia-induced Mobitz type I AV will reduce the occurrence of Wenckebach.
- Open Access
- 1 October 2020
- Published by Elsevier in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
- Vol. 4 (5) , 506-510
Status of Acute Myocardial Infarction in Southern India During COVID-19 Lockdown: A Multicentric Study
- 1 October 2020
- Published by Elsevier in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
- Vol. 4 (5) , 506-510
Open AccessStatus of Acute Myocardial Infarction in Southern India During COVID-19 Lockdown: A Multicentric Study
- 1 October 2020
- Published by Elsevier in Medical Hypotheses
- Vol. 143, 109849
Protective effects of vaccinations and endemic infections on COVID-19: A hypothesis
- 1 October 2020
- Published by Elsevier in Medical Hypotheses
- Vol. 143, 109849
Protective effects of vaccinations and endemic infections on COVID-19: A hypothesis
- Open Access
- 1 September 2020
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 59 (3) , 444-445
Plastic Bag With Holes as an Alternative to Face Shield: Our Experiences
- 1 September 2020
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 59 (3) , 444-445
Open AccessPlastic Bag With Holes as an Alternative to Face Shield: Our Experiences
- Open Access
- 6 August 2020
- Published by Springer Nature in Research Square
Status of Heart Failure During COVID-19 Lockdown: A Multi-centric Study From Southern India
Background:Severe acute respiratory distress syndrome coronavirus (SARS CoV2) infection (COVID-19) has affected many countries globally. During COVID-19 lockdown, there has been a reduction in emergency room presentations and subsequent hospital admissions for many diseases. Objective: Our aim was to find out the statusof heart failure (HF) cases treated in the hospitals of during COVID-19 lockdown period, and to compare these with those cases treated during no-lockdown period and highlight the possible reasons for variations. Methods: A retrospective observational study was carried out across the nine-private hospitals located in four different cities of Tamil Nadu state, Southern India. Data on HF and emergency room attendance were collected for lockdown period (April 2020) and no-lockdown period (February 2020 as well as April 2019 and 2018) and analysed statistically. Results: During the lockdown period, there were 30 to 33% reductions in the emergency room attendance, whereas the total HF cases were more than no-lockdown period. Among HF, the proportion of ischemic HF was decreased, but the proportion of non-ischemic HF was increased, and these were independent of gender and ejection fraction sub-category. Discussion: Our observations of reduction in ischemic HF was attributable to steep reduction in air quality index in these cities, and a rise in non-ischemic HF could be due to doctor centred practice, lack of doctor-patient communication, under-utilisation of healthcare technologies including telehealth services, and poor compliance resulting in acute decompensation.
- 6 August 2020
- Published by Springer Nature in Research Square
Open AccessStatus of Heart Failure During COVID-19 Lockdown: A Multi-centric Study From Southern India
Background:Severe acute respiratory distress syndrome coronavirus (SARS CoV2) infection (COVID-19) has affected many countries globally. During COVID-19 lockdown, there has been a reduction in emergency room presentations and subsequent hospital admissions for many diseases. Objective: Our aim was to find out the statusof heart failure (HF) cases treated in the hospitals of during COVID-19 lockdown period, and to compare these with those cases treated during no-lockdown period and highlight the possible reasons for variations. Methods: A retrospective observational study was carried out across the nine-private hospitals located in four different cities of Tamil Nadu state, Southern India. Data on HF and emergency room attendance were collected for lockdown period (April 2020) and no-lockdown period (February 2020 as well as April 2019 and 2018) and analysed statistically. Results: During the lockdown period, there were 30 to 33% reductions in the emergency room attendance, whereas the total HF cases were more than no-lockdown period. Among HF, the proportion of ischemic HF was decreased, but the proportion of non-ischemic HF was increased, and these were independent of gender and ejection fraction sub-category. Discussion: Our observations of reduction in ischemic HF was attributable to steep reduction in air quality index in these cities, and a rise in non-ischemic HF could be due to doctor centred practice, lack of doctor-patient communication, under-utilisation of healthcare technologies including telehealth services, and poor compliance resulting in acute decompensation.
- Open Access
- 15 July 2020
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 63 (7) , 237-238
COVID-19 in children: reasons for uneventful clinical course
- 15 July 2020
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 63 (7) , 237-238
Open AccessCOVID-19 in children: reasons for uneventful clinical course
- Open Access
- 1 May 2019
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 94 (5) , 918-919
Acute Myocardial Infarction During Pregnancy and the Puerperium: Experiences and Challenges From Southern India
- 1 May 2019
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 94 (5) , 918-919
Open AccessAcute Myocardial Infarction During Pregnancy and the Puerperium: Experiences and Challenges From Southern India
- Open Access
- 1 January 2017
- Published by Scitechnol Biosoft Pvt. Ltd. in Journal of Universal Surgery
- Vol. 04 (03)
A Five Year Audit of DC Cardioversion for Patients with Atrial Fibrillation in East London
Background: Atrial fibrillation in high risk patients increases the risk of thromboembolic events which in turn increases the morbidity and mortality. Aim: This audit was conducted to evaluate DC cardioversion for patients with atrial fibrillation in East London. Methods: This retrospective audit investigates the success of DC cardioversion immediately after cardioversion therapy and at follow-up six weeks later. It also investigates waiting times for and complications resulting from said therapy. Result: A total of 729 patients were referred for cardioversion and 531 patients received DC cardioversion during the five-year period from 2009 to 2013. Yearly success rates for the period of the study ranged an astounding 84% to 94% immediately after DC cardioversion, and at 6th week follow-up, the success rate remained impressive ranging from 59% to 61%. All standards were met except for a wait time of less than one week for all patients, though this wait time was far below national mandates and in most cases significantly shorter than regional guidelines. Further, there were no complications indicating DC cardioversion is extraordinarily safe when properly administered by skilled professionals.
- 1 January 2017
- Published by Scitechnol Biosoft Pvt. Ltd. in Journal of Universal Surgery
- Vol. 04 (03)
Open AccessA Five Year Audit of DC Cardioversion for Patients with Atrial Fibrillation in East London
Background: Atrial fibrillation in high risk patients increases the risk of thromboembolic events which in turn increases the morbidity and mortality. Aim: This audit was conducted to evaluate DC cardioversion for patients with atrial fibrillation in East London. Methods: This retrospective audit investigates the success of DC cardioversion immediately after cardioversion therapy and at follow-up six weeks later. It also investigates waiting times for and complications resulting from said therapy. Result: A total of 729 patients were referred for cardioversion and 531 patients received DC cardioversion during the five-year period from 2009 to 2013. Yearly success rates for the period of the study ranged an astounding 84% to 94% immediately after DC cardioversion, and at 6th week follow-up, the success rate remained impressive ranging from 59% to 61%. All standards were met except for a wait time of less than one week for all patients, though this wait time was far below national mandates and in most cases significantly shorter than regional guidelines. Further, there were no complications indicating DC cardioversion is extraordinarily safe when properly administered by skilled professionals.
- Open Access
- 19 November 2009
- Published by Springer Nature in AIDS Research and Therapy
- Vol. 6 (1) , 25
Hypothesis of snake and insect venoms against Human Immunodeficiency Virus: a review
Background: Snake and insect venoms have been demonstrated to have beneficial effects in the treatment of certain diseases including drug resistant human immunodeficiency virus (HIV) infection. We evaluated and hypothesized the probable mechanisms of venoms against HIV. Methods: Previous literatures published over a period of 30 years (1979-2009) were searched using the key words snake venom, insect venom, mechanisms and HIV. Mechanisms were identified and discussed. Results & Conclusion: With reference to mechanisms of action, properties and components of snake venom such as sequence homology and enzymes (protease or L- amino acid oxidase) may have an effect on membrane protein and/or act against HIV at multiple levels or cells carrying HIV virus resulting in enhanced effect of anti-retroviral therapy (ART). This may cause a decrease in viral load and improvement in clinical as well as immunological status. Insect venom and human Phospholipase A2 (PLA2) have potential anti-viral activity through inhibition of virion entry into the cells. However, all these require further evaluation in order to establish its role against HIV as an independent one or as a supplement.
- 19 November 2009
- Published by Springer Nature in AIDS Research and Therapy
- Vol. 6 (1) , 25
Open AccessHypothesis of snake and insect venoms against Human Immunodeficiency Virus: a review
Background: Snake and insect venoms have been demonstrated to have beneficial effects in the treatment of certain diseases including drug resistant human immunodeficiency virus (HIV) infection. We evaluated and hypothesized the probable mechanisms of venoms against HIV. Methods: Previous literatures published over a period of 30 years (1979-2009) were searched using the key words snake venom, insect venom, mechanisms and HIV. Mechanisms were identified and discussed. Results & Conclusion: With reference to mechanisms of action, properties and components of snake venom such as sequence homology and enzymes (protease or L- amino acid oxidase) may have an effect on membrane protein and/or act against HIV at multiple levels or cells carrying HIV virus resulting in enhanced effect of anti-retroviral therapy (ART). This may cause a decrease in viral load and improvement in clinical as well as immunological status. Insect venom and human Phospholipase A2 (PLA2) have potential anti-viral activity through inhibition of virion entry into the cells. However, all these require further evaluation in order to establish its role against HIV as an independent one or as a supplement.